Structural Formula Deferoxamine Mesylate (Deferoxamine 01)
Deferoxamine Mesylate
Product Images NDC 0409-2336
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Deferoxamine Mesylate (NDC 0409-2336). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Hospira Logo (Deferoxamine 02)
Principal Display Panel (500 mg Vial Label)
This is a description of a single-dose vial of Deferoxamine Mesylate solution for intravenous, intramuscular, or subcutaneous use. The vial contains 500mg/vial of Deferoxamine Mesylate solution, and it should be stored between 20-25°C (68-77°F). The unused portion of the solution should be discarded. The vial is for Rx only and should be distributed by Hospira, Inc., located in Lake Forest, IL 60045 USA. The text also includes a National Drug Code (NDC) and lot number of the product.*
Principal Display Panel (500 mg Vial Carton)
Deferoxamine Mesylate for injection is a USP medicine that is available in a lyophilized form of 500 mg per vial, used for intravenous, intramuscular and subcutaneous use. The reconstituted solution should be used within 3 hours of commencement of treatment and should not be refrigerated. Turbid solutions should also not be used. The product may be stored at room temperature for a maximum of 24 hours before use. It is usually used for treatment based on the dosage as specified in the insert provided. The product should be kept in a safe place and away from the reach of children. It should be stored in a controlled room temperature of 20 to 25°C. The product is distributed by Hospira, Inc. and made in Hungary.*
Principal Display Panel (2 g Vial Label)
This text contains information about a Flip-top Vial that is for Rx use only, has an NDC code of 0409-2337-15, and contains Deferoxamine mesylate. The reconstituted expiration date is not available. It is recommended to not use the vial if it has expired or is not stored under proper conditions (15-25°C). The vial is for single-use only and should be discarded if any portion is unused. Hospira Inc. distributes it in the USA for S.C, M., orlV use.*
Principal Display Panel (2 g Vial Carton)
Deferoxamine mesylate is a medication that is distributed by Hospira, Inc. in the USA. It is provided in single-dose flip-top vials that should be discarded after use. Each vial contains 2g of deferoxamine mesylate, which is freeze-dried. The medication is intended for subcutaneous, intramuscular, or intravenous administration. It must be reconstituted with sterile water for injection and used within three hours of reconstitution to ensure its microbiological safety. The reconstituted product may be stored at room temperature, but not refrigerated, for a maximum of 24 hours before use. The usual dosage instructions can be found in the package insert. To ensure safety, the medication should be stored at 20 to 25°C and kept out of children's reach.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
